share_log

Scotiabank Upgrades Legend Biotech to Sector Outperform, Maintains Price Target to $65

Moomoo 24/7 ·  Apr 17 08:20

Scotiabank analyst George Farmer upgrades Legend Biotech (NASDAQ:LEGN) from Sector Perform to Sector Outperform and maintains the price target from $65 to $65.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment